Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2005
10/12/2005EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
10/12/2005EP1583503A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
10/12/2005EP1583500A2 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines
10/12/2005EP1583459A2 Apparatus for endoscopic surgical procedures
10/12/2005EP1583424A1 Preparation and administration of hybrid cell vaccines for the prevention of cancer
10/12/2005EP1583423A2 Intradermal cellular delivery using narrow gauge micro-cannula
10/12/2005EP1272666B1 A functional assay of high-density lipoprotein
10/12/2005EP1259814B1 Bcmp-7 as marker for diagnosis of breast cancer
10/12/2005EP0669979B1 C-c ckr-1, c-c chemokine receptor
10/12/2005CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy
10/12/2005CN1681920A Modified ADMTS4 molecules and method of use thereof
10/12/2005CN1681919A Chicken astrovirus type 2
10/12/2005CN1681918A Transplant acceptance inducing cells of monocytic origin and their preparation and use
10/12/2005CN1681917A Animal protein free media for cultivation of cells
10/12/2005CN1681845A Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
10/12/2005CN1681838A Nogo受体拮抗剂 Nogo receptor antagonist
10/12/2005CN1681535A Hydroxyalkyl amidon-allergen compositions
10/12/2005CN1681530A IHNV G protein for immune stimulation
10/12/2005CN1681529A Immunogenic compositions and diagnostic and therapeutic uses thereof
10/12/2005CN1680592A Diagnostic assay
10/12/2005CN1680554A Penicillium marneffei thymus resistant glubolin, its coding sequence and use
10/12/2005CN1680551A Gene of regulating epithelial cell channel of small intestine and its preparation and use
10/12/2005CN1680549A Dendritic cell obtained by antigen pulsing
10/12/2005CN1680451A Immune responses against HPV antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
10/12/2005CN1680447A Neutralizing high affinity human monoclonal antibodies specific to respiratory syncytial virus f-protein
10/12/2005CN1680445A Antithemolytic streptococcus, staphylococcus and candida albicans lgG antibody and preparation thereof
10/12/2005CN1680434A Streptococcus pneumoniae antigens
10/12/2005CN1680432A Viral protein
10/12/2005CN1679966A Nanometer grainy and mucosal immunity of antiatherosclerosis nucleic vaccine
10/12/2005CN1679963A Coupling agent of CB and specific immune globulin IgG and use thereof
10/12/2005CN1679935A Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
10/12/2005CN1679934A Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
10/12/2005CN1679933A Self-emulsifying vaccine adjuvant and preparation thereof
10/12/2005CN1679932A Ordered molecular presentation of antigens, method of preparation and use
10/12/2005CN1679931A Canine distemper virus separated in korea and recombined vaccine therefrom
10/12/2005CN1679930A Human papilloma virus and heat shock protein recombinant protein vaccine and use thereof
10/12/2005CN1679929A Streptococcal c5a peptidase vaccine
10/12/2005CN1679928A Compositions for detection and diagnosis of infectious mycobacterial diseases
10/12/2005CN1679915A Peptide antagonists of zonulin and methods for use of the same
10/12/2005CN1222619C Method of enhancing immune responses to herpes simplex virus vaccine and its pharmaceutical use
10/12/2005CN1222618C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
10/12/2005CN1222617C Chemotactic factor receptos 88-2B [CKR-3] and 88C and their antibodies
10/12/2005CN1222612C Method of extensive culture of antigen-specific cytotoxic T cells
10/12/2005CN1222540C Monoclonal antibodies anti-CD6 and their uses
10/12/2005CN1222314C Heat resisting lyophilized protectant for chicken Marek's disense turkey herpes virus lyophilized vaccine and preparing process thereof
10/12/2005CN1222313C Staphlococcus aureus preparation and producing method thereof
10/11/2005US6953778 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
10/11/2005US6953675 Landscaped antibodies and antibody fragments for clinical use
10/11/2005US6953666 Immunoassay method, analysis using antibody to bind the amino acid, or protein that has undergone oxidation, contains sulfur- or selenium amino acids, detecting oxidative damage
10/11/2005US6953662 Follistatin-3
10/11/2005US6953661 Method of preventing transport of a neurotropic virus and identifying agents for achieving same
10/11/2005US6953581 Porcine circovirus and parvovirus vaccine
10/11/2005US6953579 Chimeric virus-like particle or chimeric capsomers from BPV
10/11/2005US6953577 Human methionine aminopeptidase type 3
10/11/2005US6953573 Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
10/11/2005US6953568 Administering biological conjugates that bind preferentially to endothelial protein C receptor(EPCR), to endothelial cells of vascular systems; genetic translocation; drug delivery
10/11/2005US6953211 Anti-panic opening system for doors
10/11/2005CA2341276C Human anti-factor ix/ixa antibodies
10/11/2005CA2087272C Cd53 cell surface antigen and use thereof
10/06/2005WO2005093427A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 50 (gpr50)
10/06/2005WO2005093422A2 Carbohydrate-encapsulated quantum dots for biological imaging
10/06/2005WO2005093070A1 Recombinant herpesvirus and utilization of the same
10/06/2005WO2005093063A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy
10/06/2005WO2005093048A1 Cancerous disease modifying antibodies
10/06/2005WO2005093043A1 Dna immunocontraceptive vaccines and uses thereof
10/06/2005WO2005092925A2 Immunoglobulin variants outside the fc region
10/06/2005WO2005092922A2 Antigen of the pm-2 antibody and use thereof
10/06/2005WO2005092918A2 Targeting polypeptide
10/06/2005WO2005092381A1 Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis
10/06/2005WO2005092380A2 Uses of anti-ctla-4 antibodies
10/06/2005WO2005092378A2 Anti-vglut glutamate transporter antibodies for use in pain therapy
10/06/2005WO2005092377A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/06/2005WO2005092376A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
10/06/2005WO2005092375A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
10/06/2005WO2005092374A2 Recombinant herpes simplex virus and uses therefor
10/06/2005WO2005092373A1 Method for amplifying therapeutic vaccine activity
10/06/2005WO2005092372A2 Modified bacillus anthracis vaccine compositions and methods of use thereof
10/06/2005WO2005092371A1 Hybrid cell vaccine
10/06/2005WO2005092073A2 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
10/06/2005WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/06/2005WO2005091991A2 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
10/06/2005WO2005091853A2 Methods and compositions for treating il-13 related pathologies
10/06/2005WO2005091805A2 Methods and compositions for inhibition of metastasis
10/06/2005WO2005091753A2 Flexible vaccine assembly and vaccine delivery platform
10/06/2005WO2005080939A3 Method and device for detecting feline immunodeficiency virus
10/06/2005WO2005077090A3 Improved methods of producing antibody conjugates
10/06/2005WO2005075646A8 Peptide originating in stress-induced antiapoptosis molecule (iex-1)
10/06/2005WO2005074572A3 Methods and compositions for detecting of equine tapeworm infections
10/06/2005WO2005070041A3 Modulating vaccine against hiv nef protein-induced lymphocyte depletion
10/06/2005WO2005062820A9 Multi plasmid system for the production of influenza virus
10/06/2005WO2005051330A3 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT
10/06/2005WO2005048938A3 Anti-pecam therapy for metastasis suppression
10/06/2005WO2005028496A3 Vaccine for treatment and prevention of herpes simplex virus infection
10/06/2005WO2005027844A3 Dna vaccine compositions and methods of use
10/06/2005WO2005026388A3 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
10/06/2005WO2005025614A3 Improvements in vaccination
10/06/2005WO2005025518A3 Inhibition of inward sodium currents in cancer
10/06/2005WO2005019434A3 Serine protease inhibitors for treatment of bacterial infections
10/06/2005WO2005000884A8 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
10/06/2005WO2004078912A8 Chicken rna polymerase i promoter and the use thereof
1 ... 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 ... 1823